Roche & Sunostik launched the first RS600 laboratory automated system in Shanxi

At the beginning of this year, Roche Diagnostics China and Changchun Sunostik Medical Technology Co., Ltd. entered into a strategic partnership and jointly launched a new RS600 laboratory automated system for the Chinese market. Recently, the first RS600 LAS has officially landed in the People's Hospital of Xiangning County, Linfen City, Shanxi Province. With more efficient, flexible and economical automation solutions, RS600 can meet the needs of different medical and health institutions for diversified and high-quality diagnostic solutions, and improve the accessibility of high-quality medical resources.

Booth No. of Roche: A6-0801、A4-0109

Booth No. of Sunostik: A5-0818

The improvement of the hospital's comprehensive strength is inseparable from the support of laboratory medicine. As a bridge between clinical medicine and basic medicine, the laboratory plays a vital role in clinical diagnosis and treatment by providing accurate, reliable and timely inspection reports, helping clinicians quickly judge the condition, seizing the best opportunity for diagnosis and treatment, and improving the treatment effect.

In the era of smart medicine, the automation and intelligent upgrading of laboratory medicine is an indispensable link in the construction of modern medical service capacity. In the past, LAS were mainly concentrated in large tertiary hospitals. Many grassroots hospitals were limited by operating costs, sample size, space and other factors, which made it difficult to popularize and apply them on a large scale.

The RS600, by integrating the advantages of domestic and foreign technical resources, adopts an integrated pre-processing design. According to the specific needs of the laboratory, such as the sample size and space size, it uses modular and customized solutions to achieve flexible layout of the laboratory, optimize the work process, improve the quality of testing, and at the same time control the operating cost, which solves the difficulties of the laboratory in standardization, testing efficiency and operation management.

It is reported that RS600 can quickly and accurately identify samples with a rail speed of up to 3600 tubes/hour by virtue of carrying radio frequency identification (RFID) technology and high-speed "chain board" technology.

RS600 is adapted to Roche diagnostic COBAS analyzer, including biochemical, immune, blood coagulation and other modules, to improve detection efficiency. In addition, Roche Diagnostics also provides RS600 users with a full range of services, including professional assembly line service teams, overall laboratory solutions, full laboratory design and other "one-stop" services.

After Xiangning County People's Hospital introduced the RS600, the sample pretreatment and other steps that needed to be completed manually would be completed by RS600, which not only saved the investment of human resources for the laboratory, optimized the hospital's laboratory workflow, improved the laboratory's biological security, reduced the laboratory's biological security risks, and effectively benefited medical staff and patients while improving the detection efficiency and quality.

Yao Guoliang, general manager of Roche Diagnostics China, said: "Adhering to the concept of" Rooting in China and Serving China ", Roche Diagnostics is committed to introducing the world's leading in vitro diagnostic solutions into China. In recent years, Roche Diagnostics has continued to promote local innovation, actively explored innovative business models with outstanding enterprises, and helped China's medical industry develop with high quality. The RS600 LAS cooperation project is an important milestone for Roche Diagnostics to build an integrated diagnosis and treatment ecosystem with outstanding local enterprises. In the future, Roche Diagnostics will continue to enable local cooperation and innovation, jointly promote the construction of an integrated ecosystem of diagnosis and treatment, help China's overall medical level continue to improve, and benefit the general public. "